PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg) – Investors Business Daily

SAN DIEGO–(BUSINESS WIRE)–POZEN Inc. (NASDAQ: POZN),a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster …

Leave a Reply

Your email address will not be published. Required fields are marked *

*